Growth Metrics

Gilead Sciences (GILD) Total Liabilities (2016 - 2026)

Gilead Sciences filings provide 17 years of Total Liabilities readings, the most recent being $36.3 billion for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 8.43% to $36.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $36.3 billion, a 8.43% decrease, with the full-year FY2025 number at $36.3 billion, down 8.43% from a year prior.
  • Total Liabilities hit $36.3 billion in Q4 2025 for Gilead Sciences, down from $37.1 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $48.5 billion in Q1 2021 to a low of $35.4 billion in Q2 2024.
  • Median Total Liabilities over the past 5 years was $40.5 billion (2023), compared with a mean of $40.9 billion.
  • Biggest five-year swings in Total Liabilities: increased 29.19% in 2021 and later dropped 14.21% in 2024.
  • Gilead Sciences' Total Liabilities stood at $46.9 billion in 2021, then dropped by 10.51% to $42.0 billion in 2022, then dropped by 6.16% to $39.4 billion in 2023, then grew by 0.73% to $39.7 billion in 2024, then fell by 8.43% to $36.3 billion in 2025.
  • The last three reported values for Total Liabilities were $36.3 billion (Q4 2025), $37.1 billion (Q3 2025), and $36.1 billion (Q2 2025) per Business Quant data.